|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1989-06-05 |
Randomized, double-blind, placebo-controlled study on FPF1100NW monotherapy with early Parkinson's disease patients (Phase III study)
Long-term study on FPF1100NW monotherapy with early Parkinson's disease patients
Study on FPF1100NW monotherapy with early Parkinson's disease patients (Phase II study)
100 项与 FP Pharmaceutical Corporation 相关的临床结果
0 项与 FP Pharmaceutical Corporation 相关的专利(医药)
100 项与 FP Pharmaceutical Corporation 相关的药物交易
100 项与 FP Pharmaceutical Corporation 相关的转化医学